Somatostatin analog (octreotide) in management of neonatal postoperative chylothorax: is it safe?
OBJECTIVE
Somatostatin and its analogs have recently been introduced in the treatment of chylous effusions in infants and children following surgery. The safety profile of this treatment in critically ill patients has not been fully evaluated.


METHODS
Retrospective case review.


METHODS
Tertiary pediatric cardiac center.


METHODS
A male infant born by cesarean section with a birth weight of 2.6 kg.


METHODS
None.


CONCLUSIONS
We report the association of postoperative chylothorax treated with somatostatin analog (octreotide) and necrotizing enterocolitis in an infant following aortic coarctation repair.
Mohseni-Bod
Hadi
H
Paediatric Intensive Care Unit, Royal Brompton & Harefield NHS Trust, Royal Brompton Hospital, London, UK.
Macrae
Duncan
D
Slavik
Zdenek
Z
D001017:Aortic Coarctation / Q000601:surgery; D006348:Cardiac Surgical Procedures / Q000009:adverse effects*; D002916:Chylothorax / Q000188:drug therapy* / Q000209:etiology; D005765:Gastrointestinal Agents / Q000627:therapeutic use*; D006801:Humans; D007231:Infant, Newborn; D008297:Male; D015282:Octreotide / Q000627:therapeutic use*; D011183:Postoperative Complications / Q000188:drug therapy*
D005765:Gastrointestinal Agents; D015282:Octreotide